These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8503648)

  • 1. Adverse effects of pharmaceutical excipients in drug therapy.
    Wong YL
    Ann Acad Med Singap; 1993 Jan; 22(1):99-102. PubMed ID: 8503648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
    Abrantes CG; Duarte D; Reis CP
    J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of common pharmaceutical excipients on the gut microbiota.
    Subramaniam S; Kamath S; Ariaee A; Prestidge C; Joyce P
    Expert Opin Drug Deliv; 2023; 20(10):1297-1314. PubMed ID: 37307224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging the Gap: A Comparative Investigation of Pharmaceutical Excipient Regulations.
    Mali A; Kuvar V; Bharadwaj S
    Ther Innov Regul Sci; 2024 Mar; 58(2):258-272. PubMed ID: 38055157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clarification of terminology in drug safety.
    Aronson JK; Ferner RE
    Drug Saf; 2005; 28(10):851-70. PubMed ID: 16180936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new approach to the safety assessment of pharmaceutical excipients. The Safety Committee of the International Pharmaceutical Excipients Council.
    Steinberg M; Borzelleca JF; Enters EK; Kinoshita FK; Loper A; Mitchell DB; Tamulinas CB; Weiner ML
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):149-54. PubMed ID: 8933628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of error estimated from Palestine pharmacists' knowledge and certainty on the adverse effects and contraindications of active pharmaceutical ingredients and excipients.
    Shawahna R; Al-Rjoub M; Al-Horoub MM; Al-Hroub W; Al-Rjoub B; Al-Nabi BA
    J Educ Eval Health Prof; 2016; 13():1. PubMed ID: 26743774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicines containing pharmaceutical excipients with known effects: a French review.
    Fusier I; Tollier C; Husson MC
    Pharm World Sci; 2003 Aug; 25(4):152-5. PubMed ID: 12964493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are excipients really inert ingredients? A review of adverse reactions to excipients in oral dermatologic medications in Canada.
    Noiles K; Vender R
    J Cutan Med Surg; 2010; 14(3):105-14. PubMed ID: 20487670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and pattern of pharmaceutical and excipient exposure in a neonatal unit in Slovenia.
    Fister P; Urh S; Karner A; Krzan M; Paro-Panjan D
    J Matern Fetal Neonatal Med; 2015; 28(17):2053-61. PubMed ID: 25316561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro hemolysis: guidance for the pharmaceutical scientist.
    Amin K; Dannenfelser RM
    J Pharm Sci; 2006 Jun; 95(6):1173-6. PubMed ID: 16639718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmaceutical development aimed at improving safety for children].
    Andrieu V; Reynier JP
    Therapie; 2004; 59(6):599-601. PubMed ID: 15789821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact Of Excipient Variability On Drug Product Processing And Performance.
    Peng Soh JL; Liew CV; Sia Heng PW
    Curr Pharm Des; 2015; 21(40):5890-9. PubMed ID: 26446469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
    Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic excipients: Importance of clinical awareness of inactive ingredients.
    Ionova Y; Wilson L
    PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excipient pharmacokinetics and profiling.
    Loftsson T
    Int J Pharm; 2015 Mar; 480(1-2):48-54. PubMed ID: 25596414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
    Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
    Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of various analytical techniques in quality control of pharmaceutical excipients.
    Kumar M; Bhatia R; Rawal RK
    J Pharm Biomed Anal; 2018 Aug; 157():122-136. PubMed ID: 29787965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of excipients--a Food and Drug Administration perspective.
    Osterberg RE; See NA
    Int J Toxicol; 2003; 22(5):377-80. PubMed ID: 14555410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.